Rhabdomyolysis reports show interaction between simvastatin and CYP3A4 inhibitors
Author:
Publisher
Wiley
Subject
Pharmacology (medical),Epidemiology
Reference34 articles.
1. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update - Endorsed by the National Heart, Lung, and Blood Institute;Smith;Circulation,2006
2. HMG-CoA reductase inhibitors and myotoxicity;Ucar;Drug Saf,2000
3. Cerivastatin and reports of fatal rhabdomyolysis;Staffa;N Engl J Med,2002
4. Tissue selectivity of pravastatin sodium, lovastatin and simvastatin - the relationship between inhibition of denovo sterol synthesis and active-drug concentrations in the liver, spleen and testis in rat;Koga;Eur J Biochem,1992
5. Pharmacokinetic and, pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions;Shitara;Pharmacol. Ther.,2006
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Endoscopic diagnosis and management of nonvariceal upper gastrointestinal hemorrhage (NVUGIH): European Society of Gastrointestinal Endoscopy (ESGE) Guideline – Update 2021;Endoscopy;2021-02-10
2. Treatment patterns of lipid‐lowering therapies and possible statin intolerance among statin users with clinical atherosclerotic cardiovascular disease (ASCVD) or diabetes mellitus (DM) in Taiwan;Journal of Evaluation in Clinical Practice;2019-10-23
3. The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies;Therapeutics and Clinical Risk Management;2019-07
The clinical significance of statins-macrolides interaction: comprehensive review of in vivo studies, case reports, and population studies
4. Trends and variations in outpatient coprescribing of simvastatin or atorvastatin with potentially interacting drugs in Thailand;Therapeutic Advances in Drug Safety;2019-01
5. Onset timing of statin‐induced musculoskeletal adverse events and concomitant drug‐associated shift in onset timing of MAE s;Pharmacology Research & Perspectives;2018-11-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3